Thomas Kofoed, Ph.D, CEO
Dr. Kofoed has as Chief Executive Officer of Alphalyse been responsible for general management of Alphalyse since its inception. He has more than 15 years of experience from the Biotech industry, and previous posts include Head of Proteomics at ACE BioSciences, Associated Professor at Copenhagen University and Senior Scientist at PNA Diagnostics.
Dr. Kofoed has established business partnerships with major pharma and biotech companies as well as commercialization agreements with laboratory supply organizations. He obtained his Ph.D. in organic chemistry from University of Southern Denmark in 1996, and holds a bachelor degree in business administration (HA).
Ejvind Mørtz, Ph.D, COO
Dr. Mørtz has as founder and Chief Operating Officer been with Alphalyse since its inception. He has more than 15 years experience in the pharma and biotech industry as co-founder and COO of ACE BioSciences, Head of Proteomics Applications of MDS Proteomics, and Post Doctoral scientist at Astra. He has commercial experience through establishment of numerous collaborations and licensing agreements with biotech and pharmaceutical companies.
He has project management experience from several vaccine and antibody discovery projects, taking these through pre-clinical development into clinical trials. He has a scientific background in proteomics and mass spectrometry and has 19 scientific publications. He obtained his Ph.D. in protein chemistry and molecular biology in 1996 from University of Southern Denmark.